Agenda
Thursday, October 17, 2024
Session 1: Histone Modifications and Chromatin Structure
Chair: David Clark, Ph.D., National Institute of Child Health and Human Development, NIH
Brian Strahl, Ph.D., University of North Carolina at Chapel Hill
Shelley Berger, Ph.D., University of Pennsylvania
Ali Shilatifard, Ph.D., Northwestern University
Tom Muir, Ph.D., Princeton University
Session 2: Chromatin Remodeling
Chair: Mirit Aladjem, Ph.D., Center for Cancer Research, NCI
Carl Wu, Ph.D., Johns Hopkins University
Jerry Crabtree, Ph.D., Stanford University
Cigall Kadoch, Ph.D., Harvard Medical School
Steve Henikoff, Ph.D., Fred Hutch Cancer Center
Session 3: Chromatin Modifications and Gene expression
Chair: Ann Dean, Ph.D., National Institute of Diabetes and Digestive and Kidney Diseases, NIH
Emily Bernstein, Ph.D., Icahn School of Medicine at Mount Sinai
Asifa Akhtar, Ph.D., Max Planck Institute
Yi Zhang, Ph.D., Harvard Medical School
Payel Sen, Ph.D., National Institute of Aging, NIH
Friday, October 18, 2024
Session 4: Chromatin Organization and Dynamics
Chair: Elissa Lei, Ph.D., National Institute of Diabetes and Digestive and Kidney Diseases, NIH
Genevieve Almouzni, Ph.D., Curie Institute
Iestyn Whitehouse, Ph.D., Memorial Sloan Kettering Cancer Center
Todd Macfarlan, Ph.D., National Institute of Child Health and Human Development, NIH
Bing Ren, Ph.D., University of California, San Diego
Gordon Hager, Ph.D., Center for Cancer Research, NCI
Session 5: Histone Modifications and Development
Chair: Yamini Dalal, Ph.D. Center for Cancer Research, NCI
Joanna Wysocka, Ph.D., Stanford University
Eva Nogales, Ph.D., University of California, Berkeley
Kenneth Zaret, Ph.D., University of Pennsylvania
Yawen Bai, Ph.D., Center for Cancer Research, NCI
Session 6: Histone Modifications and Gene Silencing
Chair: Alan Hinnebusch, Ph.D., National Institute of Child Health and Human Development, NIH
Peter Lewis, Ph.D., University of Wisconsin, Madison
Kathrin Plath, Ph.D., University of California, Los Angeles
Thomas Jenuwein, Ph.D., Max Planck Institute
Shiv Grewal, Ph.D., Center for Cancer Research, NCI